{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:39Z","timestamp":1740185019305,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00108-024-01715-1","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:10:44Z","timestamp":1717506644000},"page":"690-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mukosaassoziierte Lymphome des Gastrointestinaltrakts","Gastrointestinal mucosa-associated lymphoma"],"prefix":"10.1007","volume":"65","author":[{"given":"Wolfgang","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-8760","authenticated-orcid":false,"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-5986","authenticated-orcid":false,"given":"Gabriele","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"1715_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow\u00a0SH, Campo\u00a0E, Pileri\u00a0SA et\u00a0al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390","journal-title":"Blood"},{"issue":"Suppl. 142","key":"1715_CR2","first-page":"135","volume":"23","author":"JI Wyatt","year":"1998","unstructured":"Wyatt\u00a0JI, Rathbone\u00a0BJ (1998) Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 23(Suppl. 142):135\u2013140","journal-title":"Scand J Gastroenterol"},{"key":"1715_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/jcp.42.12.1269","volume":"42","author":"M Stolte","year":"1989","unstructured":"Stolte\u00a0M, Eidt\u00a0S (1989) Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J\u00a0Clin Pathol 42:1269\u20131271. https:\/\/doi.org\/10.1136\/jcp.42.12.1269","journal-title":"J Clin Pathol"},{"key":"1715_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"A Wotherspoon","year":"1991","unstructured":"Wotherspoon\u00a0A, Ortiz-Hidalgo\u00a0C, Falzon\u00a0MR, Isaacson\u00a0PG (1991) Helicobacter pylori-associated gastritis and primary B\u2011cell gastric lymphoma. Lancet 338:1175\u20131176","journal-title":"Lancet"},{"key":"1715_CR5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0016-5085(97)70028-3","volume":"112","author":"M Eck","year":"1997","unstructured":"Eck\u00a0M, Schmau\u00dfer\u00a0W, Haas\u00a0R et\u00a0al (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112:1482\u20131486","journal-title":"Gastroenterology"},{"key":"1715_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1055\/s-2004-813537","volume":"42","author":"W Fischbach","year":"2004","unstructured":"Fischbach\u00a0W (2004) Gastrointestinale Lymphome. Z\u00a0Gastroenterol 42:1067\u20131072","journal-title":"Z Gastroenterol"},{"key":"1715_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1055\/a-0581-5736","volume":"56","author":"W Fischbach","year":"2018","unstructured":"Fischbach\u00a0W (2018) Colorectal MALT lymphoma: a\u00a0rare clinical entity. Experiences from a\u00a0clinical series. Z\u00a0Gastroenterol 56:905\u2013911","journal-title":"Z Gastroenterol"},{"key":"1715_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit\u00a0M, Abachin\u00a0E, Martin\u00a0M et\u00a0al (2004) Immuneproliferative small intestinal disease associated with Campylobacter jejuni. N\u00a0Engl J Med 350:239\u2013248","journal-title":"N Engl J Med"},{"key":"1715_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/gut.2010.224949","volume":"60","author":"A Ruskon\u00e9-Fourmestraux","year":"2011","unstructured":"Ruskon\u00e9-Fourmestraux\u00a0A, Fischbach\u00a0W, Aleman\u00a0BMP et\u00a0al (2011) EGILS consensus report. Gastric extranodal marginal zone B\u00a0cell lymphoma of MALT. Gut 60:747\u2013758","journal-title":"Gut"},{"key":"1715_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1055\/a-1975-0414","volume":"61","author":"W Fischbach","year":"2023","unstructured":"Fischbach\u00a0W, Bornschein\u00a0J, Hoffmann\u00a0JC et\u00a0al (2023) Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z\u00a0Gastroenterol 61:544\u2013606","journal-title":"Z Gastroenterol"},{"key":"1715_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"A Wotherspoon","year":"1993","unstructured":"Wotherspoon\u00a0A, Doglioni\u00a0C, Diss\u00a0TC et\u00a0al (1993) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575\u2013577","journal-title":"Lancet"},{"key":"1715_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1055\/s-2005-921045","volume":"37","author":"D Flieger","year":"2005","unstructured":"Flieger\u00a0D, Keller\u00a0R, May\u00a0A et\u00a0al (2005) Capsule Endoscopy in Gastrointestinal lymphomas. Endoscopy 37:1174\u20131180","journal-title":"Endoscopy"},{"key":"1715_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/gut.52.6.912","volume":"52","author":"A Ruskone-Fourmestraux","year":"2003","unstructured":"Ruskone-Fourmestraux\u00a0A, Dragosics\u00a0B, Morgner\u00a0A et\u00a0al (2003) Paris staging system for primary gastrointestinal lymphomas. Gut 52:912\u2013913","journal-title":"Gut"},{"key":"1715_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1053\/gast.2000.19579","volume":"119","author":"W Fischbach","year":"2000","unstructured":"Fischbach\u00a0W, Dragosics\u00a0B, Koelve-Goebeler\u00a0ME et\u00a0al (2000) Primary gastric B\u2011cell lymphoma: results of a\u00a0prospective multicenter study. Gastroenterology 119:1191\u20131202","journal-title":"Gastroenterology"},{"key":"1715_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0016-5107(02)70119-3","volume":"56","author":"W Fischbach","year":"2002","unstructured":"Fischbach\u00a0W, Goebeler-Kolve\u00a0ME, Greiner\u00a0A (2002) Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a\u00a0prospective, multicenter study comparing EUS with histopathologic stage. Gastrointest Endosc 56:696\u2013700","journal-title":"Gastrointest Endosc"},{"key":"1715_CR16","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1200\/JCO.2001.19.18.3874","volume":"19","author":"P Koch","year":"2001","unstructured":"Koch\u00a0P, Del Valle\u00a0F, Berdel\u00a0WE et\u00a0al (2001) Primary Gastrointestinal Non-Hodgkin\u2019s Lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma\u2014results of the prospective german multicenter study GIT NHL 01\/92. J\u00a0Clin Oncol 19:3874\u20133883","journal-title":"J Clin Oncol"},{"key":"1715_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0029-1246012","volume":"49","author":"W Fischbach","year":"2011","unstructured":"Fischbach\u00a0W, Schramm\u00a0S, Goebeler\u00a0E (2011) Outcome and quality of life favour a\u00a0conservative treatment of patients with primary gastric lymphoma. Z\u00a0Gastroenterol 49:1\u20136","journal-title":"Z Gastroenterol"},{"key":"1715_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.sla.0000129356.81281.0c","volume":"240","author":"SS Yoon","year":"2004","unstructured":"Yoon\u00a0SS, Coit\u00a0DG, Portlock\u00a0CS, Karpeh\u00a0MS (2004) The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 240:28\u201337. https:\/\/doi.org\/10.1097\/01.sla.0000129356.81281.0c","journal-title":"Ann Surg"},{"key":"1715_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1055\/s-2006-927272","volume":"45","author":"W Fischbach","year":"2007","unstructured":"Fischbach\u00a0W, Keller\u00a0R, Englert\u00a0D (2007) Unusual treatment of a\u00a0gastric marginal zone B\u2011Cell lymphoma of MALT type. Z\u00a0Gastroenterol 45:383\u2013386","journal-title":"Z Gastroenterol"},{"key":"1715_CR20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(95)90113-2","volume":"345","author":"E Bayerd\u00f6rffer","year":"1995","unstructured":"Bayerd\u00f6rffer\u00a0E, Rudolph\u00a0B, Neubauer\u00a0A et\u00a0al (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591\u20131594","journal-title":"Lancet"},{"key":"1715_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"HC Zullo","year":"2010","unstructured":"Zullo\u00a0HC, Cristofari\u00a0F et\u00a0al (2010) Effects of helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8:105\u2013110","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1715_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gut.53.1.34","volume":"53","author":"W Fischbach","year":"2004","unstructured":"Fischbach\u00a0W, Goebeler-Kolve\u00a0ME, Dragosics\u00a0B et\u00a0al (2004) Long term outcome of patients with gastric marginal zone B\u00a0cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a\u00a0large prospective series. Gut 53:34\u201337","journal-title":"Gut"},{"issue":"31","key":"1715_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T W\u00fcndisch","year":"2005","unstructured":"W\u00fcndisch\u00a0T, Thiede\u00a0C, Morgner\u00a0A et\u00a0al (2005) Long-Term follow-up of gastric MALT lymphoma after helicobacter pylori eradication. J\u00a0Clin Oncol 23(31):1\u20137","journal-title":"J Clin Oncol"},{"key":"1715_CR24","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.gastro.2012.06.035","volume":"143","author":"T W\u00fcndisch","year":"2012","unstructured":"W\u00fcndisch\u00a0T, Dieckhoff\u00a0P, Greene\u00a0B et\u00a0al (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by helicobacter pylori eradication and followed for 10 years. Gastroenterology 143:936\u2013942","journal-title":"Gastroenterology"},{"key":"1715_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(02)09711-8","volume":"360","author":"W Fischbach","year":"2002","unstructured":"Fischbach\u00a0W, Goebeler-Kolve\u00a0M, Starostik\u00a0P et\u00a0al (2002) Minimal residual low-grade gastric MALT-type lymphoma after eradication of helicobacter pylori. Lancet 360:547\u2013548","journal-title":"Lancet"},{"key":"1715_CR26","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1136\/gut.2006.096420","volume":"56","author":"W Fischbach","year":"2007","unstructured":"Fischbach\u00a0W, Goebeler\u00a0ME (2007) Ruskone-Fourmestraux, et\u00a0al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be safely managed by a\u00a0watch-and-wait strategy. Experience from a\u00a0large international series. Gut 56:1685\u20131687","journal-title":"Gut"},{"key":"1715_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/a-1108-3778","volume":"57","author":"W Fischbach","year":"2019","unstructured":"Fischbach\u00a0W, Dorl\u00f6chter\u00a0C (2019) Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a\u00a0watch-and-wait strategiy. Z\u00a0Gastroenterol 57:1\u20137","journal-title":"Z Gastroenterol"},{"key":"1715_CR28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gut.2005.083022","volume":"55","author":"M Raderer","year":"2006","unstructured":"Raderer\u00a0M, Streubel\u00a0B, W\u00f6hrer\u00a0S, H\u00e4fner\u00a0M (2006) Chott A Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 55:616\u2013618","journal-title":"Gut"},{"issue":"10","key":"1715_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","volume":"47","author":"A Zullo","year":"2013","unstructured":"Zullo\u00a0A, Hassan\u00a0C, Ridola\u00a0L et\u00a0al (2013) Eradication therapy in helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients. J\u00a0Clin Gastroenterol 47(10):824\u2013827","journal-title":"J Clin Gastroenterol"},{"key":"1715_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom\u00a0J, Illidge\u00a0T, Specht\u00a0L et\u00a0al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol 92:11\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.009","journal-title":"Int J Radiat Oncol"},{"key":"1715_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00066-019-01446-5","volume":"195","author":"G Reinartz","year":"2019","unstructured":"Reinartz\u00a0G, Pyra\u00a0RP, Lenz\u00a0G et\u00a0al (2019) Erfolgreiche Strahlenfeldverkleinerung bei gastralem Marginalzonenlymphom: Erfahrungen der Deutschen Studiengruppe Gastrointestinale Lymphome (DSGL). Strahlenther Onkol 195:544\u2013557. https:\/\/doi.org\/10.1007\/s00066-019-01446-5","journal-title":"Strahlenther Onkol"},{"key":"1715_CR32","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/jco.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch\u00a0P, Probst\u00a0A, Berdel\u00a0WE et\u00a0al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the german multicenter study (GIT NHL 02\/96). J\u00a0Clin Oncol 23:7050\u20137059. https:\/\/doi.org\/10.1200\/jco.2005.04.031","journal-title":"J Clin Oncol"},{"key":"1715_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/s0360-3016(99)00475-7","volume":"46","author":"NA Willich","year":"2000","unstructured":"Willich\u00a0NA, Reinartz\u00a0G, Horst\u00a0E et\u00a0al (2000) Operative and conservative management of primary gastric lymphoma: Interim results of a\u00a0German multicenter study. Int J Radiat Oncol 46:895\u2013901. https:\/\/doi.org\/10.1016\/s0360-3016(99)00475-7","journal-title":"Int J Radiat Oncol"},{"key":"1715_CR34","unstructured":"NCCN Guidelines B\u2011cell Lymphomas Version\u00a06.2023. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1480"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01715-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T07:03:22Z","timestamp":1719385402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01715-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01715-1","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"23 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"W. Fischbach: A. Finanzielle Interessen: gibt an, dass kein finanzieller Interessenkonflikt besteht. - B. Nichtfinanzielle Interessen: Chefarzt, Medizinische Klinik II und Klinik f\u00fcr Palliativmedizin, Klinikum Aschaffenburg-Alzenau, Akademisches Lehrkrankenhaus der Universit\u00e4t W\u00fcrzburg. Freier Mitarbeiter (Teilzeit) Gastroenterologische Gemeinschaftspraxis Aschaffenburg | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Arbeitsgemeinschaft Leitender Gastroenterologischer Krankenhaus\u00e4rzte (ALGK), Berufsverband Niedergelassener Gastroenterologen Deutschlands (BNG).A.\u00a0Neubauer: A. Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Deutsche Forschungsgemeinschaft (DFG), Krebshilfe, Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung, Stiftung Innovative Lehre. \u2013\u00a0CSL Behring, Vortrag auf Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Onkologie (DGHO) 20.\u00a0\u2013 B. Nichtfinanzielle Interessen: Professor f\u00fcr Innere Medizin, Chefarzt\/Direktor, Klinik f\u00fcr Innere Medizin mit Schwerpunkt H\u00e4matologie, Onkologie, Immunologie, Universit\u00e4tsklinikum Gie\u00dfen und Marburg GmbH, Standort Marburg | Mitgliedschaften: Wissenschaftlicher Beirat der Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung, Mitglied im klinischen Studienausschuss der DFG, Mitglied der Leopoldina, stellvertretender Vorstand der Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung. G. Reinartz: A. Finanzielle Interessen: gibt an, dass kein finanzieller Interessenkonflikt besteht. - B. Nichtfinanzielle Interessen: Angestellte \u00c4rztin, Klinik f\u00fcr Strahlentherapie,  Universit\u00e4tsklinikum M\u00fcnster | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Radioonkologie (DEGRO), Deutsche Krebsgesellschaft (DKG), German Lymphoma Alliance (GLA), International Lymphoma Radiation Oncology Group (ILROG).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}